West Pharmaceutical Services Inc. buy KeyCorp
Start price
13.02.24
/
50%
€373.10
Target price
13.02.25
€438.98
Performance (%)
-27.37%
Price
23.08.24
€270.60
Summary
This prediction is currently active. The prediction for West Pharmaceutical Services Inc. disappoints with a performance of -27.37%. Dividends of €0.37 are taken into consideration when calculating the performance. This prediction currently runs until 13.02.25. The prediction end date can be changed by KeyCorp at any time. KeyCorp has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
West Pharmaceutical Services Inc. | -0.697% | -0.697% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by KeyCorp for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at KeyCorp from $440.00 to $470.00. They now have an "overweight" rating on the stock.
Ratings data for WST provided by MarketBeat
Stopped prediction by KeyCorp for West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€331.80
28.07.23
28.07.23
€349.62
28.07.24
28.07.24
-19.98%
29.07.24
29.07.24